Insilico Medicine plans to push its computer-designed drug into pivotal clinical trials after a phase 2a study demonstrated ...

The topline data showed ISM001-055 to have improved the forced vital capacity (FVC) of IPF patients studied 12 weeks after ...

In a small Phase IIa trial, Insilico’s generative AI-designed idiopathic pulmonary fibrosis drug improved lung function and ...

Insilico Medicine(“Insilico”), a global leading generative artificial intelligence (AI)-driven biotechnology company, will be hosting Pharma.AI Week featuring in-depth webinar series from November ...

Sino-American firm Insilico Medicine has shown the potential not just of its pipeline and lead candidate by presenting ...

Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.

Insilico Medicine(“Insilico”), a global leading generative artificial intelligence (AI)-driven biotechnology company, ...

The development of a novel, artificial intelligence (AI)-generated biotechnology has the potential to transform care options ...

Find out how AI is transforming healthcare in India with better diagnostics, predictive analytics, and patient care.

Chinese startups can develop digital avatars almost as good as human streamers using just a few minutes of footage, noted ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...